Dr. Xiaolin Zhang, MD

Dr. Zhang practices at Dlv Vision Management in Westlake Village, California.

Dr. Zhang's NPI, 1063739928, was assigned on April 30, 2010. Dr. Zhang graduated from Rutgers Robert Wood Johnson Medical School in 2010. Dr. Zhang holds California license A135328.

Dr. Zhang's primary practice is Dlv Vision Management, at 4353 Park Terrace Dr, Westlake Village, CA 91361 in Ventura County. The practice phone is (805) 987-5300.

Dr. Zhang's primary practice is Dlv Vision Management in Westlake Village, California. Dmand AI also links Dr. Zhang to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhang practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Zhang's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Zhang is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Zhang's licenses on file in 4 states: California, New York, Ohio and Pennsylvania.

Dmand AI lists cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Zhang treats.

CMS data shows 1,976 Medicare services from Dr. Zhang across 17 procedure codes in 2024, for 581 Medicare patients. Medicare paid $206,304 for them.

CMS counts 581 Medicare patients who saw Dr. Zhang in 2024. The largest group is 65 to 74, with 244 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zhang's median patient age at 70, with 66% women.

In 2024, Dr. Zhang wrote 1,248 Medicare Part D claims for 313 patients. 34% of them were for generic drugs. CMS names the drug for 1,165 of them, across 22 drugs with 11 or more claims each, at $2,083,287 in total drug cost. In 2023, CMS named 977 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Zhang for performance year 2024, reported individually. Dr. Zhang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 127 procedures of cataract surgery by Dr. Zhang, more than 78% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Zhang, published from 2013 to 2018. 2015 was the busiest year, with 2. The most frequent topics are Cell Line, Tumor, Disease Models, Animal and Protein Kinase Inhibitors. Dr. Zhang's most frequent co-authors are Luke Apisa and Venkateswara Vinod Mootha, MD.

CMS Open Payments shows 266 general payments to Dr. Zhang from 27 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Sun Pharmaceutical Industries Inc. paid the most, $1,149.

Dr. Zhang graduated from Rutgers Robert Wood Johnson Medical School in 2010.

Dr. Zhang is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.